Nov62023

MHRA authorises enzyme inhibitor Anastrozole to prevent breast cancer in post-menopausal women

image_pdfimage_print

Anastrozole is now authorised as a preventative treatment for post-menopausal women at moderate or high risk of breast cancer.

Leave a Reply

Your email address will not be published.